Transcription Factor EB (TFEB) Expression and Localization in the Third-Trimester Placenta
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110294 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cinzia Giacometti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Pederzoli Hospital, Peschiera del Garda, 37019 Verona, Italy. Hauptthemen laut MEDLINE: Placenta, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Pregnancy Trimester, Third. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transcription factor EB (TFEB) is expressed at high levels in the trophoblast cells of the placenta, where it plays a critical role in regulating normal vascularization. Preeclampsia (PE) is a severe complication of pregnancy with a high incidence of maternal and fetal morbidity and mortality. Gestational diabetes (GD) is a metabolic disease that can affect placental villous maturation and villous vascularity. We analyzed the expression of three different antibodies: TFEB from Invitrogen (TFEB-INV), which detects endogenous levels of TFEB only when phosphorylated at Ser211; TFEB from Bethyl Labs (TFEB-B), which recognizes and binds E-box sequences; and TFEB from Santa Cruz (C-6) (TFEB-SC), which is specifically used for epitope mapping between 440 and 470. We evaluated the presence/absence of TFEB in six placental districts: syncytiotrophoblast (STB), cytotrophoblast (CTB), extravillous trophoblast (EVT), syncytial knots, stem villi vessels, and villous capillaries. TFEB-B was significantly expressed in the stem villi vessels, STB, and villi vessels of GD cases. The lack of TFEB expression in late-onset PE appears to corroborate the role of TFEB in vascular remodeling during placental development. The positive results in STB and vessels in GD cases, regardless of the histological diagnosis, may suggest that the expression of TFEB mitigates hypoxic injury via the Akt/mTOR pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, Pederzoli Hospital, Peschiera del Garda, 37019 Verona, Italy.
- IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milano, Italy.
- Gynecology & Obstetrics Unit, Pederzoli Hospital, Peschiera del Garda, 37019 Verona, Italy.
- Pathology Unit, Department of Diagnostic and Public Health, University of Verona, 37126 Verona, Italy.
ORCID-Profile: Cinzia Giacometti, Alessandro Ambrosi
Zitieren
APA
Giacometti, C., Ambrosi, A., Cavaliere, S., Caliò, A., Mautone, D., & Martignoni, G. (2025). Transcription Factor EB (TFEB) Expression and Localization in the Third-Trimester Placenta. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110294
Vancouver
Giacometti C, Ambrosi A, Cavaliere S, Caliò A, Mautone D, Martignoni G. Transcription Factor EB (TFEB) Expression and Localization in the Third-Trimester Placenta. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110294
BibTeX
@article{Giacometti2025,
author = {Giacometti, Cinzia and Ambrosi, Alessandro and Cavaliere, Serena and Caliò, Anna and Mautone, Daniele and Martignoni, Guido},
title = {Transcription Factor EB (TFEB) Expression and Localization in the Third-Trimester Placenta},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110294}
}
EUVIMED